Published in Med Clin (Barc) on September 27, 1997
[Optic neuritis and the risk of development of multiple sclerosis]. Med Clin (Barc) (1998) 0.75
MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology (2007) 2.47
Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology (2008) 2.45
The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol (2000) 2.10
New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology (2003) 2.04
[Effectiveness of smoking cessation intervention in patients with cardiovascular disease]. Rev Esp Cardiol (2001) 1.93
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg (1998) 1.72
Pituitary enlargement in patients with intracranial hypotension syndrome. Neurology (2000) 1.71
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. Neurology (2008) 1.62
Lumbar extradural hemangiomas: report of three cases. AJNR Am J Neuroradiol (1999) 1.55
Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler (2009) 1.49
New anatomical classification of the axilla with implications for sentinel node biopsy. Br J Surg (2010) 1.46
Hemifacial spasm associated with Paget's disease of bone: good response to calcitonin. Neurology (1991) 1.42
[Adnexal masses management: a prospective multicentric observational study]. Gynecol Obstet Fertil (2008) 1.42
Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology (2006) 1.42
[Descriptive study of first visits in a multiple sclerosis specialised unit]. Neurologia (2002) 1.39
[The influence of the arterial pressure in the study of cerebrovascular reactivity in carotid obstructions]. Rev Neurol (2001) 1.39
[Isolated axial lateral pulse as a sign of latero-bulbar ischemia: clinical topographic correlation]. Rev Neurol (1997) 1.39
[Body mass index influence in the insulin action mechanisms]. An Med Interna (1998) 1.38
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? Mult Scler (2005) 1.36
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Prospective evaluation of late cosmetic results following breast reconstruction: I. Implant reconstruction. Plast Reconstr Surg (2001) 1.27
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin Cancer Res (2000) 1.24
Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients. Mult Scler (2008) 1.21
Encephalopathy associated to autoimmune thyroid disease: a more appropriate term for an underestimated condition? J Neurol Sci (2000) 1.20
A care bundle approach for prevention of ventilator-associated pneumonia. Clin Microbiol Infect (2012) 1.17
Complications of lymphadenectomy for gynecologic cancer. Eur J Surg Oncol (2012) 1.14
High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology (2004) 1.13
MRI findings in Möbius syndrome: correlation with clinical features. Neurology (2000) 1.13
Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol (2005) 1.12
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients. Endocr Relat Cancer (2006) 1.11
Ischemic stroke in young adults. I. Analysis of the etiological subgroups. Acta Neurol Scand (1989) 1.11
Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg (1995) 1.11
mTOR signalling in human cancer. Clin Transl Oncol (2007) 1.09
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis. Neurology (2006) 1.09
Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS. Neurology (1998) 1.09
Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis. Mult Scler (2001) 1.09
Brainstem lesions in clinically isolated syndromes. Neurology (2010) 1.09
Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response. Eur J Neurol (2012) 1.07
MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. Br J Cancer (2011) 1.06
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler (2009) 1.04
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04
Impaired tyrosine-kinase activity of muscle insulin receptors from hypomagnesaemic rats. Diabetologia (1995) 1.04
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology (2007) 1.04
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04
Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler (2008) 1.03
Fatigue in multiple sclerosis persists over time: a longitudinal study. J Neurol (2006) 1.02
Patulin accumulation in apples by Penicillium expansum during postharvest stages. Lett Appl Microbiol (2007) 1.02
Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas. Br J Surg (2012) 1.02
Automatic detection of patients with nosocomial infection by a computer-based surveillance system: a validation study in a general hospital. Infect Control Hosp Epidemiol (2006) 1.00
Clinical impact of early brain atrophy in clinically isolated syndromes. Mult Scler (2013) 1.00
Reappraisal of the intracranial pressure and cerebrospinal fluid dynamics in patients with the so-called "normal pressure hydrocephalus" syndrome. Acta Neurochir (Wien) (1991) 0.99
The basal ganglia: a substrate for fatigue in multiple sclerosis. Neuroradiology (2007) 0.99
Mitral papillary fibroelastoma as a cause of cardiogenic embolic stroke: report of two cases and review of the literature. Eur J Neurol (2000) 0.99
Cerebral infarction after excessive use of nasal decongestants. J Neurol Neurosurg Psychiatry (1989) 0.99
Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology (1999) 0.99
One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.99
Adipose-tissue grafting to the post-mastectomy irradiated chest wall: preparing the ground for implant reconstruction. J Plast Reconstr Aesthet Surg (2011) 0.98
A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. Neurology (2010) 0.98
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? Br J Cancer (2007) 0.98
Asterixis associated with anatomic cerebral lesions: a study of 45 cases. Acta Neurol Scand (1995) 0.98
Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98
C-MET as a new therapeutic target for the development of novel anticancer drugs. Clin Transl Oncol (2010) 0.98
Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol (2001) 0.97
Computed tomography in reversible ischaemic attacks: clinical and prognostic correlations in a prospective study. J Neurol (1988) 0.97
Sterilization reversal: fertility results. Hum Reprod (1995) 0.97
Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors. Am J Physiol (1991) 0.97
Transient ischaemic attack: a common initial manifestation of cardiac myxomas. Eur Neurol (2001) 0.97
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler (2013) 0.97